Upcoming biologic agents for the treatment of rheumatic diseases

被引：45
|
作者：
Shanahan, JC [1 ]
Moreland, LW [1 ]
Carter, RH [1 ]
机构：
[1] Univ Alabama Birmingham, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA
来源：
CURRENT OPINION IN RHEUMATOLOGY | 2003年 / 15卷 / 03期
关键词：
D O I：
10.1097/00002281-200305000-00009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The development of biologic agents has provided rheumatologists with a variety of new and effective treatment options. The success of early biologics, especially etanercept and infliximab for the treatment of rheumatoid arthritis, has spurred research into novel targets for the management of systemic inflammatory and autoimmune diseases. In addition, existing biologics approved for use in other diseases, such as rituximab, are now under study for the treatment of new indications. This article reviews ongoing research on the treatment of rheumatic diseases with new and existing biologic agents.
引用
收藏
页码：226 / 236
页数：11
相关论文
共 50 条
  • [1] OPTIMIZING TREATMENT OF RHEUMATIC DISEASES WITH BIOLOGIC AGENTS IN OUR DAY HOSPITAL
    Calvo, J.
    Castro, M. D. C.
    Escudero, A.
    Collantes Estevez, E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 934 - 934
  • [2] Use of biologic agents for rheumatic diseases in pregnancy
    Yesim Garip
    [J]. World Journal of Rheumatology, 2015, (02) : 50 - 58
  • [3] PReS13-SPK-1579: Biologic agents for the treatment of rheumatic diseases
    P Emery
    [J]. Pediatric Rheumatology, 11 (Suppl 2)
  • [4] Central demyelination due to biologic agents in rheumatic diseases
    Arslan, D.
    Sayinalp-Arslan, B.
    Acar-Ozen, P.
    Bilgin, E.
    Ertenli, I.
    Kiraz, S.
    Kalyoncu, U.
    Karabudak, R.
    Tuncer, A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 453 - 453
  • [5] BIOLOGIC AGENTS IN RHEUMATIC DISEASES - A REAL LIFE EXPERIENCE
    Stanic, M.
    Skocibusic, N.
    Zekic, T.
    Novak, S.
    Vlahovic-Palcevski, V.
    [J]. CLINICAL THERAPEUTICS, 2015, 37 (08) : E42 - E43
  • [6] QUALITY INDICATORS FOR USE OF BIOLOGIC AGENTS IN RHEUMATIC DISEASES
    Suyama, Y.
    Kishimoto, M.
    Rokutanda, R.
    Min, C.
    Haji, Y.
    Ohara, Y.
    Shimizu, H.
    Yamaguchi, K. -I.
    Matsui, Y.
    Okada, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 486 - 486
  • [7] BIOLOGIC AGENTS IN AUTOIMMUNE RHEUMATIC DISEASES AND BONE HEALTH
    Athanassiou, L.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S102 - S102
  • [8] Introduction to Special Section: Biologic Agents in the Treatment of Rheumatic Diseases-The First Decade
    Yelin, Edward
    Katz, Patricia
    [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (05): : 559 - 559
  • [9] Biologic Agents in the Treatment of Rheumatic Diseases with Chronic Viral Infection. Where Are We?
    Wendling, Daniel
    Di Martino, Vincent
    Herbein, Georges
    [J]. JOURNAL OF RHEUMATOLOGY, 2009, 36 (06) : 1107 - 1108
  • [10] Safety of biologic agents for the management of rheumatic diseases during pregnancy
    D'Gama, Jonathan D.
    Bermas, Bonnie L.
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2024, 36 (03) : 184 - 190
12345